Iproniazid Phosphate

Overview

Hydralazine is antihypertensive agent. It acts as a vasodilator. It relaxes and expands blood vessels and lowers the blood pressure. It also function as antioxidant. It has been available for many years, though it was initially thought not to be particularly effective because tachyphylaxis to hypertensive effects developed rapidly. Now the benefits of combination therapy are recognized, and may be used more effectively particularly in severe hypertension.

Categories

• 24 Psychotherapeutic drugs
  • 24.2 Drugs used in mood disorders
  • 24.2.1 Drugs used in depression

Page headings

Primary Characterstics

Indications

Hydralazine (HCl) is primarily indicated in conditions like Benign gastric and duodenal ulcers, Heart failure, Hypertension, Hypertension with renal complications and hypertensive crisis (including during pregnancy), Hypertensive emergencies, Moderate to severe hypertension, Moderate to severe hypertension (adjunct), Primary pulmonary hypertension, Severe or recurrent duodenal and gastric ulcertion, and can also be given in adjunctive therapy as an alternative drug of choice in Heart failure (with long acting nitrate).

Pharmacokinetics

Contraindications

Drug Interactions

Side Effects

Dosage

Iproniazid Phosphate's dosage details are as follows:

Dose	Single Dose	Frequency	Route	Instructions
Adult Dosage
50 to 150 mg	100 (100)	As recommended.	oral
Paedriatic Dosage (20kg)
No data regarding the Paedriatic dosage details of Iproniazid Phosphate is available.
Neonatal Dosage (3kg)
No data regarding the neonatal dosage details of Iproniazid Phosphate is available.

High Risk Groups

Warning / Precautions

Storage Conditions

Interference in Pathology

Brands / Trade Names of Iproniazid Phosphate

Manufacturers of Iproniazid Phosphate in Pakistan

Back to top